Skip to content
OpenCapital
Get started

Allogene Therapeutics ALLO Market capitalization

Market capitalization at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$123.83B-0.2%
Gilead Sciences logo
Gilead SciencesGILD
$172.99B+23.8%
Precigen logo
PrecigenPGEN
$1.37B+213%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$4.57B+56.4%
Sana Biotechnology logo
Sana BiotechnologySANA
$768.58M+103%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$1.02B+1,895%

Other financials

Income statement

See full
Revenue-—
Operating income-$46.1M+29.3%
Net income-$42.6M+28.7%
EPS (diluted)-$0.18+35.7%

Balance sheet

See full
Cash & equivalents$40.6M-23.0%
Total debt$81.1M-8.9%
Total equity$278.9M-27.6%
Total assets$396.0M-22.1%

Cash flow

See full
Operating cash flow-$12.9M+75.6%
CapEx$9.0K-90.9%
Free cash flow-$12.9M+75.6%

Valuation

See full
Enterprise value$751.47M+146%

Profitability

See full
Operating margin-1,241,813.6%-2,018,140pp
Net margin-1,170,863.6%-2,007,890pp
FCF margin-913,609.1%-1,474,890pp

Returns & leverage

See full
Return on equity-52.3%-5.7pp
Debt / equity0.3×+0.1×
Current ratio9.6×-0.1×

Where this comes from

Computed from the period-end share price: $594.82M.

The official record: Allogene Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Allogene Therapeutics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Allogene Therapeutics's market capitalization?
Allogene Therapeutics (ALLO) reported market capitalization of $594.82M in Q1 2026.
How has Allogene Therapeutics's market capitalization changed year-over-year?
Allogene Therapeutics's market capitalization increased by 87.5% year-over-year, from $317.21M to $594.82M.
What is the long-term trend for Allogene Therapeutics's market capitalization?
Over 5 years (2020 to 2025), Allogene Therapeutics's market capitalization has grown at a -38.8% compound annual growth rate (CAGR), from $3.6B to $307.88M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.